Mayo Clinic researchers take a step closer to developing a DNA test for liver cancer

WASHINGTON, D.C. ? A group of researchers from Mayo Clinic?and Exact Sciences Corporation?have completed a phase II study comparing a set of DNA markers to alpha fetoprotein as a method to test for liver cancer. The researchers presented their findings today at the 2018 Digestive Disease Week?conference in Washington, D.C. ?We currently test for liver [...]
Source: Mayo Clinic Minnesota News - Category: Hospital Management Source Type: news